» Articles » PMID: 32812250

Medicinal Plants Used Against Various Inflammatory Biomarkers for the Management of Rheumatoid Arthritis

Overview
Specialties Pharmacology
Pharmacy
Date 2020 Aug 20
PMID 32812250
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Rheumatoid arthritis is a chronic autoimmune disease manifested clinically by polyarthralgia associated with joint dysfunction triggering the antibodies targeting against the self-neoepitopes determined by autoimmune responses associated with chronic arthritic attacks. The activation of macrophages and other defence cells in response to self-epitopes as biomarkers in RA provides a better understanding of pathogenesis of disease and has led to the development of novel therapeutic approaches acting as potent inhibitors of these cells.

Key Findings: The current review retrieved the various medicinal plants possessing an active phytoconstituents with anti-inflammatory and antioxidant properties, which tends to be effective alternative approach over the synthetic drugs concerned with high toxic effects. The current available literature provided an evident data concluding that the active constituents like fatty acids, flavonoids, terpenes and sesquiterpene lactones attenuate the RA symptoms by targeting the inflammatory biomarkers involved in the pathogenesis of RA.

Summary: Despite the various synthetic treatment approaches targeting immune cells, cytokines improved the quality of life but still the drug management is challenging due to toxic and chronic teratogenic effects with anti-arthritic drugs. The current review has elaborated the selected traditionally used herbal medicinal plants with phytoconstituents possessing anti-inflammatory activity by suppressing the inflammatory biomarkers with lesser side effects and providing the future exploration of natural drug therapy for rheumatoid arthritis.

Citing Articles

Unraveling the hormonal approaches for the treatment of rheumatoid arthritis and its complementary interventions.

Waghmare P, Kaushik D, Oz E, Proestos C, Oz F, Kumar M Inflammopharmacology. 2025; 33(2):443-460.

PMID: 39754003 DOI: 10.1007/s10787-024-01633-6.


Deep learning based predictive modeling to screen natural compounds against TNF-alpha for the potential management of rheumatoid arthritis: Virtual screening to comprehensive in silico investigation.

Nabi T, Riyed T, Ornob A PLoS One. 2024; 19(12):e0303954.

PMID: 39636801 PMC: 11620472. DOI: 10.1371/journal.pone.0303954.


Relationship Between Serum Interleukin-6 Levels, Systemic Immune-Inflammation Index, and Other Biomarkers Across Different Rheumatoid Arthritis Severity Levels.

Zeb S, Khan Z, Ashraf , Javaid M, Rumman , Swati M Cureus. 2024; 16(10):e72334.

PMID: 39469275 PMC: 11516189. DOI: 10.7759/cureus.72334.


Beyond Pharmaceuticals: Harnessing the Potential of Plant-based Compounds for Anti-inflammatory Therapy.

Mittal V, Sharma A Recent Adv Inflamm Allergy Drug Discov. 2024; 18(2):90-107.

PMID: 39404108 DOI: 10.2174/0127722708292961240508110207.


Anti-arthritic studies of ethnomedicine Gaultheria trichophylla Royle extract and salicylate-rich fraction using complete Freud's adjuvant-induced rats: molecular docking and network pharmacology analysis.

Alam F, Ahmad A, Rauf K, Alamri A, Alsanie W Inflammopharmacology. 2024; 32(6):3785-3798.

PMID: 39312098 DOI: 10.1007/s10787-024-01572-2.